Company Filing History:
Years Active: 2021-2025
Title: Simon Richard Carding: Innovator in Gut Microbiome Research
Introduction
Simon Richard Carding is a notable inventor based in Norwich, GB. He has made significant contributions to the field of microbiome research, particularly in the development of innovative methods for delivering therapeutic proteins and vaccines using gut bacteria.
Latest Patents
Carding holds three patents, with his latest inventions focusing on the engineering of gut commensal bacteria. One of his notable patents is titled "Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract." This invention pertains to the delivery of heterologous peptides or proteins, such as therapeutic peptides, therapeutic proteins, or antigens, to mucosal sites using vesicles derived from the outer membrane of commensal bacteria. It also includes recombinant bacteria capable of producing such vesicles and methods for their production. Another significant patent is "Gut bacteria derived microvesicles for vaccine delivery," which relates to a vaccine suitable for immunization against influenza and plague. This vaccine comprises outer membrane vesicles (OMVs) and includes the V and/or F1 antigens.
Career Highlights
Throughout his career, Simon Richard Carding has worked with esteemed organizations such as Quadram Institute Bioscience and UEA Enterprises Limited. His work has been pivotal in advancing the understanding of gut microbiome applications in medicine.
Collaborations
Carding has collaborated with various professionals in his field, including Regis Gabriel Stentz, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Simon Richard Carding's innovative work in gut microbiome research and his patents reflect his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches and vaccine delivery systems.